Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Cited by (853)

Items 101–200 of 853

1. Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials
   Potpara, Tatjana S, Mujovic, Nebojsa, Proietti, Marco, Dagres, Nikolaos, Hindricks, Gerhard, Collet, Jean-Phillipe, Valgimigli, Marco, Heidbuchel, Hein, Lip, Gregory Y H · 2020 · EP Europace
2. Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies
   Roskell, Neil S., Samuel, Miny, Noack, Herbert, Monz, Brigitta U. · 2013 · EP Europace
3. Reinitiation of Anticoagulation After Warfarin-Associated Intracranial Hemorrhage and Mortality Risk: The Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) Study
   Derek Yung, Moira K. Kapral, Eriola Asllani, Jiming Fang, Douglas S. Lee · 2011 · Canadian Journal of Cardiology
4. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
   Dominick Joseph Angiolillo, Shaun G. Goodman, Deepak L. Bhatt, John W. Eikelboom, Matthew J. Price, David J. Moliterno, Christopher Paul Cannon, Jean‐François Tanguay, Christopher Bull Granger, Laura Mauri et al. · 2016 · Circulation Cardiovascular Interventions
5. The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties
   Bernard Iung, Josep Rodés‐Cabau · 2014 · European Heart Journal
6. One‐Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry
   A. Rubboli, A. Schlitt, T. Kiviniemi, F. Biancari, P. Karjalainen, J. Valencia, M. Laine, P. Kirchhof, M. Niemelä, S. Vikman et al. · 2014 · Clinical Cardiology
7. Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions
   Sara R. Vazquez · 2018 · Blood
8. An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial
   Renato D. Lópes, Amit N. Vora, Danny Liaw, Christopher Bull Granger, Harald Darius, Shaun G. Goodman, Roxana Mehran, Stephan Windecker, John Hunter Alexander · 2018 · American Heart Journal
9. Left Atrial Appendage Occlusion
   David R. Holmes, Dhanunjaya Lakkireddy, Richard Paul Whitlock, Ron Waksman, Michael J. Mack · 2013 · Journal of the American College of Cardiology
10. Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial
    Pascal Vranckx, Thorsten Lewalter, Marco Valgimigli, Jan G.P. Tijssen, Paul‐Egbert Reimitz, Lars Eckardt, Hans‐Joachim Lanz, Wolfgang Zierhut, Rüdiger Smolnik, Andreas Goette · 2017 · American Heart Journal
11. Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study
    Hedi Schelleman, Colleen M Brensinger, Warren B. Bilker, Sean Hennessy · 2011 · PLoS ONE
12. Upper Gastrointestinal Bleeding in Adults: Evaluation and Management.
    Thad Wilkins, Brittany Wheeler, Mary Carpenter · 2020 · PubMed
13. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
    Miklós Rohla, Thomas Werner Weiss, Ladislav Pecen, Giuseppe Patti, Jolanta Maria Siller-Matula, Renate B. Schnabel, RICHARD JOHN SCHILLING, Dipak Kotecha, Markus Lucerna, Kurt Huber et al. · 2019 · BMJ Open
14. Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA
    Azmil H. Abdul‐Rahim, Rachael L. Fulton, Benedikt Frank, Turgut Tatlisumak, Maurizio Paciaroni, Valeria Caso, HC Diener, Kennedy R. Lees, the VISTA collaborators · 2014 · European Journal of Neurology
15. Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation
    Vincent Johan Nijenhuis, Naoual Bennaghmouch, Mariëlla E.C.J. Hassell, Jan Baan, Jan Peter van Kuijk, Pierfrancesco Agostoni, Arnoud W.J. van ’t Hof, Peter C. Kievit, Leo F. Veenstra, Pim van der Harst et al. · 2015 · American Heart Journal
16. Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy
    Philip M. Urban, Alexandre Abizaid, Bernard Chevalier, Samantha Greene, Ian T. Meredith, Marie‐Claude Morice, Stuart Pocock · 2013 · American Heart Journal
17. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti‐inflammatory drugs, low‐dose aspirin, antiplatelet drugs, and dual therapy
    Naoyoshi Nagata, Ryota Niikura, Tomonori Aoki, Takuro Shimbo, Yoshihiro Kishida, Katsunori Sekine, Shohei Tanaka, Kazuhiro Watanabe, Toshiyuki Sakurai, Chizu Yokoi et al. · 2014 · Journal of Gastroenterology and Hepatology
18. Management of Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation in the Setting of Acute Coronary Syndromes or Percutaneous Coronary Interventions
    Davide Capodanno, Dominick Joseph Angiolillo · 2014 · Circulation Cardiovascular Interventions
19. Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes
    Arlene M. Gallagher, Tjeerd Pieter van Staa, Tarita Murray‐Thomas, Nils Schoof, Andreas Clemens, Diana Ackermann, Dorothee B. Bartels · 2014 · BMJ Open
20. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe
    Juhani K.E. Airaksinen, Thomas Cuisset, Francisco R. Marín, Andrea Rubboli, Andrea Rubboli, Gregory Y.H. Lip, Kurt Huber · 2011 · Thrombosis and Haemostasis
21. Antithrombotic Therapy for Peripheral Artery Disease
    Hussain, Mohamad A., Al-Omran, Mohammed, Creager, Mark A., Anand, Sonia S., Verma, Subodh, Bhatt, Deepak L. · 2018 · Journal of the American College of Cardiology
22. Management of Patients With NSTE-ACS
    Fátima Rodríguez, Kenneth W. Mahaffey · 2016 · Journal of the American College of Cardiology
23. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
    Diana Adrienne Gorog, Ying Xuan Gue, Tze‐Fan Chao, Laurent Fauchier, José Luis Ferreiro, Kurt Huber, Stavros Konstantinides, Deirdre A. Lane, Francisco R. Marín, Jonas Oldgren et al. · 2022 · EP Europace
24. Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence
    Stefano Cacciatore, Luigi Spadafora, Marco Bernardi, Mattía Galli, Matteo Betti, Francesco Perone, Giulia Nicolaio, Emanuele Marzetti, Anna Maria Martone, Francesco Landi et al. · 2023 · Journal of Clinical Medicine
25. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation
    Fei Gao, Yu Jie Zhou, Zhi Jian Wang, Shi Wei Yang, Bin Nie, Xiao Li Liu, De An Jia, Zhen Xian Yan · 2010 · International Journal of Cardiology
26. Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events
    Jordan K. Schaefer, Yun Li, Xiaokui Gu, Nicole M. Souphis, Brian Haymart, Eva M Kline-Rogers, STEVEN L. ALMANY, Scott S. Kaatz, J Kozłowski, Gregory D Krol et al. · 2019 · JAMA Internal Medicine
27. Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations
    Osung Kwon, Duk‐Woo Park · 2022 · JACC Asia
28. Adverse Drug Events in Patients with Chronic Kidney Disease Associated with Multiple Drug Interactions and Polypharmacy
    Julia C. Sommer, Andreas Seeling, Harald Rupprecht · 2020 · Drugs & Aging
29. Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage
    Michael T. C. Poon, Catherine J. Rea, Angelos Georgiou Kolias, Paul Martin Brennan, Fardad T. Afshari, Aminul Islam Ahmed, Sai Deepak Alli, Rafid Al-Mahfoudh, Jarnail Singh Bal, Antonio Belli et al. · 2018 · Journal of Neurotrauma
30. Risk of Bleeding on Triple Antithrombotic Therapy After Percutaneous Coronary Intervention/Stenting: A Systematic Review and Meta-analysis
    Jason G. Andrade, Marc William Deyell, Clarence Khoo, May Lee, Karin H. Humphries, John A. Cairns · 2012 · Canadian Journal of Cardiology
31. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group
    Peter Damman, Arnoud W.J. van ’t Hof, Jurriën M. ten Berg, J. Wouter Jukema, Yolande Appelman, Anho H Liem, Robbert J. de Winter · 2016 · Netherlands Heart Journal
32. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy
    Naoyoshi Nagata, Ryota Niikura, Tomonori Aoki, Takuro Shimbo, Yoshihiro Kishida, Katsunori Sekine, Shohei Tanaka, Hidetaka Okubo, Kazuhiro Watanabe, Toshiyuki Sakurai et al. · 2014 · Gastrointestinal Endoscopy
33. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial
    Rohan Shah, Anne S. Hellkamp, Yuliya V. Lokhnygina, Richard Clinton Becker, Scott D. Berkowitz, GÜNTER E. BREITHARDT, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Keith A.A. Fox et al. · 2016 · American Heart Journal
34. Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy
    Hiroshi Yasuda · 2015 · World Journal of Critical Care Medicine
35. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents
    Thomas Pilgrim, Bindu Kalesan, Thomas Zanchin, Cédric Pulver, Simon C. Jung, Heinrich Paul Mattle, Thierry Pierre Carrel, Aris Moschovitis, Stefan Stortecky, Peter Wenaweser et al. · 2013 · EuroIntervention
36. Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions
    Sara R. Vazquez · 2018 · Hematology
37. Combining antiplatelet and anticoagulant therapy in cardiovascular disease
    Geoffrey D. Barnes · 2020 · Hematology
38. Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
    Gregory Y.H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant M. Phatak · 2018 · PLoS ONE
39. 2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome
    Yi‐Heng Li, Yu-Chen Wang, Yi‐Chih Wang, Ju‐Chi Liu, Cheng‐Han Lee, Chun‐Chi Chen, Ching‐Lin Hsieh, Feng Yu Kuo, Wei‐Chun Huang, Shih‐Hsien Sung et al. · 2018 · Journal of the Formosan Medical Association
40. Update on Antithrombotic Therapy after Percutaneous Coronary Intervention
    Yuichi Saito, Yoshio Kobayashi · 2019 · Internal Medicine
41. Vitamin K antagonists with or without long‐term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events
    Gilles Lemesle, Grégory Ducrocq, Yedid Elbez, Eric VAN BELLE, Shinya Goto, Christopher Paul Cannon, Christophe Bauters, Deepak L. Bhatt, Philippe Gabríel Steg, for the REACH Investigators · 2017 · Clinical Cardiology
42. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk
    Steven A. Lubitz, Shaan S. Khurshid, Lu-Chen C Weng, Gheorghe D. Doros, Joseph Walker Keach, Qi Gao, Anil K. Gehi, Jonathan Chong Hsu, Matthew R. Reynolds, Mintu P. Turakhia et al. · 2018 · American Heart Journal
43. Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
    Andreas Schäfer, Ulrike Flierl, Dominik Berliner, Johann K Bauersachs · 2020 · Cardiovascular Drugs and Therapy
44. Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial
    Willem J.M. Dewilde, Paul W.A. Janssen, Johannes C. Kelder, Freek W.A. Verheugt, Bart J.G.L. de Smet, Tom Adriaenssens, Mathias Vrolix, Guus R. G. Brueren, Carlos A.G. van Mieghem, Kristoff Cornelis et al. · 2015 · EuroIntervention
45. The Challenge of Bleeding in Antiphospholipid Antibody-Positive Patients
    Giulia Pazzola, Stéphane Zuily, Doruk Erkan · 2015 · Current Rheumatology Reports
46. Shared Decision Making in Patients with Stable Coronary Artery Disease: PCI Choice
    Megan J. Coylewright, Kathy Shepel, Annie LeBlanc, Laurie J. Pencille, Erik P. Hess, Nilay D. Shah, Víctor M. Montori, Henry H. Ting · 2012 · PLoS ONE
47. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
    Renato D. Lópes, Meena P. Rao, DaJuanicia N. Simon, Laine Elliott Thomas, Jack Ansell, Gregg C. Fonarow, Bernard John Gersh, Alan S. Go, Elaine M. Hylek, Peter Russell Kowey et al. · 2016 · The American Journal of Medicine
48. Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis
    Nicholas Ewin Burr, Katie Lummis, Ruchit Sood, John S. Kane, Venkataraman Subramanian · 2016 · The Lancet. Gastroenterology & hepatology
49. Modern Management of ST-Segment Elevation Myocardial Infarction
    Jennifer Frampton, James T. DeVries, Terrence D. Welch, Bernard John Gersh · 2018 · Current Problems in Cardiology
50. Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention
    Willem J.M. Dewilde, Paul W.A. Janssen, Freek W.A. Verheugt, Robert F. Storey, Tom Adriaenssens, Morten Lock Hansen, Morten Lamberts, Jurriën M. ten Berg · 2014 · Journal of the American College of Cardiology
51. Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction
    Keith A.A. Fox, John W. Eikelboom, Olga Shestakovska, Stuart J. Connolly, Kaj Peter Metsarinne, Salim Yusuf · 2019 · Journal of the American College of Cardiology
52. Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis
    Liang Lin, Wee Shiong Lim, Hui Jun Zhou, Ai Leng Khoo, Keng Teng Tan, Aik Phon Chew, David Chee Guan Foo, Jing Jih Chin, Boon Peng Lim · 2015 · Journal of the American Medical Directors Association
53. Biomimetic modification of poly(vinyl alcohol): Encouraging endothelialization and preventing thrombosis with antiplatelet monotherapy
    Deirdre E.J. Anderson, Katie P. Truong, Matthew W. Hagen, Evelyn K. F. Yim, Monica T. Hinds · 2019 · Acta Biomaterialia
54. Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
    Torbjørn Fosen Wisløff, Gunhild Hagen, Marianne Klemp · 2014 · PharmacoEconomics
55. Dual antiplatelet therapy in coronary artery disease: from the past to the future prospective
    Antonio Mangieri, Francesco Gallo, Alessandro Sticchi, Arif Azhar Khokhar, Alessandra Laricchia, Francesco Giannini, Antonio Colombo · 2020 · Cardiovascular Intervention and Therapeutics
56. Warfarin use among older atrial fibrillation patients with non–ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy
    Emil Loldrup Fosbøl, Tracy Y. Wang, Shuang Li, Jonathan Paul Piccini, Renato D. Lópes, Roger M. Mills, Winslow I. Klaskala, Laine Elliott Thomas, Matthew T. Roe, Eric David Peterson · 2013 · American Heart Journal
57. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non–ST elevation myocardial infarction
    Emil Loldrup Fosbøl, Tracy Y. Wang, Shuang Li, Jonathan Paul Piccini, Renato D. Lópes, Bimal R. Shah, Roger M. Mills, Winslow I. Klaskala, Karen P. Alexander, Laine Elliott Thomas et al. · 2012 · American Heart Journal
58. Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19
    Aining Zhang, Yan Leng, Yi Zhang, Kefan Wu, Yelong Ji, Shaoqing Lei, Zhongyuan Xia · 2020 · International Journal of Infectious Diseases
59. Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure
    Andrea Lee, Mark Andrew Crowther · 2011 · Journal of Thrombosis and Thrombolysis
60. Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis
    Natalie Tapaskar, Alice S. Pang, Debra A. Werner, Neil Sengupta · 2020 · Digestive Diseases and Sciences
61. Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation
    Darae Ko, Christina L. Cove, Elaine M. Hylek · 2014 · Thrombosis and Haemostasis
62. Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists
    Rikke Sørensen, Berit Jamie Nielsen, Jannik Langtved Pallisgaard, Christina Ji‐Young Lee, Christian Tobias Torp-Pedersen · 2017 · European Heart Journal - Cardiovascular Pharmacotherapy
63. Atrial Fibrillation and Acute Myocardial Infarction: Antithrombotic Therapy and Outcomes
    Renato D. Lópes, Li Li, Christopher Bull Granger, Tracy Y. Wang, JoAnne Micale Foody, Marjorie Funk, Eric David Peterson, Karen P. Alexander · 2012 · The American Journal of Medicine
64. Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs
    Sven Pannach, Julia Goetze, Sandra Marten, Thomas Schreier, Luise Tittl, Jan Beyer‐Westendorf · 2017 · Journal of Gastroenterology
65. The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants
    Ji Yun Lee, Il‐Young Oh, Ju-Hyeon Lee, Sang-Young Kim, Seong Soon Kwon, Hyeon‐Jong Yang, Yang‐Ki Kim, Soo‐Mee Bang · 2020 · Thrombosis Research
66. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Morten Schmidt, Morten Lamberts, Anne‐Marie Schjerning Olsen, Emil Loldrup Fosbøl, Alexander Niessner, Juan Luis Tamargo, Giuseppe M.C. Rosano, Stefan Agewall, Juan Carlos Kaski, Keld P. Kjeldsen et al. · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
67. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate
    Karina Meijer, Ramiro A. Larrazabal, Fabian Arnberg, Gert Jan Luijckx, Robin S. Roberts, Sam Schulman, Ammar Majeed · 2013 · Thrombosis and Haemostasis
68. Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
    Steven Bruce Deitelzweig, Allison V. Keshishian, Amiee Luan Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa C. Rosenblatt, Jack Mardekian, Jenny Z. Jiang, Hüseyin Yüce et al. · 2021 · Therapeutic Advances in Gastroenterology
69. Delayed intracranial hemorrhage in elderly anticoagulated patients sustaining a minor fall
    Nolan Mann, Kellen Welch, Andrew St. Martin, Michael P. Subichin, Katherine Wietecha, Lauren E. Birmingham, Tiffany D. Marchand, Richard L. George · 2018 · BMC Emergency Medicine
70. Combined aspirin and anticoagulant therapy in patients with atrial fibrillation
    Charlotte H. So, Mark H. Eckman · 2016 · Journal of Thrombosis and Thrombolysis
71. Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective
    Yuichi Saito, Yoshio Kobayashi, Kengo Tanabe, Yuji Ikari · 2019 · Cardiovascular Intervention and Therapeutics
72. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
    Keith A. A. Fox, P. Velentgas, A. Camm, J. Bassand, D. Fitzmaurice, B. Gersh, S. Goldhaber, S. Goto, S. Haas, F. Misselwitz et al. · 2020 · JAMA Network Open
73. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST
    Philippe Gabríel Steg, Stefan Karl James, Dan Atar, Luigi Paolo Badano, Carina Blomström Lundqvist, Michael Andrew Borger, Carlo Di Mario, Kenneth Dickstein, Grégory Ducrocq, Francisco Fernández‐Avilés et al. · 2012 · Revista Española de Cardiología
74. Managing adverse effects and drug–drug interactions of antiplatelet agents
    Arun Kalyanasundaram, Abraham Michael Lincoff · 2011 · Nature Reviews Cardiology
75. Left atrial appendage occlusion in octogenarians
    Sameer A. Gafoor, Jennifer Franke, Stefan Christian Bertog, Patrick Boehm, Luisa Heuer, Maik Gonzaga, Janine Bauer, Annkathrin Braut, Simon Lam, Laura Vaškelytė et al. · 2013 · Catheterization and Cardiovascular Interventions
76. Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías
    Alec S. Vahanian, Friedhelm Beyersdorf, Fabien Praz, Milan Milojevic, Stephan Ernst Baldus, Johann K Bauersachs, Davide Capodanno, Lenard Conradi, Michele De Bonis, Ruggero De Paulis et al. · 2022 · Revista Española de Cardiología
77. Randomized, Double-Blind Trial to Evaluate the Safety of Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome in Japanese Patients (APPRAISE-J)
    Hisao Ogawa, Shinya Goto, Masunori Matsuzaki, Shintaro Hiro, Daisuke Shima, on behalf of the J-ROCKET AF study investigators · 2013 · Circulation Journal
78. Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice
    Alberto Corsini, Nicola Ferri, Marco Proietti, Giuseppe Boriani · 2020 · Drugs
79. Ubiquitin-proteasome system
    Rasmus Hartmann‐Petersen, Colin Gordon · 2004 · Cellular and Molecular Life Sciences
80. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI)
    Vincent Johan Nijenhuis, Naoual Bennaghmouch, Jan‐Peter van Kuijk, Davide Capodanno, Jurriën M. ten Berg · 2015 · Thrombosis and Haemostasis
81. Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
    Dawid Leander Staudacher, Paul Marc Biever, Christoph Benk, Ingo Ahrens, Christoph Bode, Tobias Wengenmayer · 2016 · PLoS ONE
82. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis
    Paul Michael Haller, Patrick Sulzgruber, Christoph Clemens Kaufmann, Bastiaan Geelhoed, Juan Luis Tamargo, Sven Waßmann, Renate B. Schnabel, Dirk Westermann, Kurt Huber, Alexander Niessner et al. · 2019 · European Heart Journal - Cardiovascular Pharmacotherapy
83. Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials
    Giuseppe Andò, Francesco Costa · 2019 · International Journal of Cardiology
84. The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation
    Laurent Azoulay, Sophie Dell’Aniello, Teresa A. Simon, Christel Renoux, Samy Suissa · 2013 · Thrombosis and Haemostasis
85. The effects of combined oral anticoagulant–aspirin therapy in patients undergoing tooth extractions
    Branislav V. Bajkin, Ivana A. Bajkin, Bojan Petrović · 2012 · The Journal of the American Dental Association
86. Antithrombotics
    Freek W.A. Verheugt, Jurriën M. ten Berg, Robert F. Storey, Thomas Cuisset, Christopher Bull Granger · 2019 · Journal of the American College of Cardiology
87. How I treat unexplained arterial thrombosis
    Jori E. May, Stephan Moll · 2020 · Blood
88. Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding
    Min‐Taek Lee, Kwang‐Yeol Park, Myo-Song Kim, Seung‐Hun You, Ye-Jin Kang, Sun‐Young Jung · 2020 · Yonsei Medical Journal
89. Bleeding Risk in Patients With Atrial Fibrillation
    Deirdre A. Lane, Pieter Willem Kamphuisen, Pascal Minini, Harry Roger Buller, Gregory Y.H. Lip · 2011 · CHEST Journal
90. Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012–2015: A Study from the Norwegian Prescription Database
    Anna Maria Urbaniak, Bjørn Oddvar Strøm, Randi Ingebjørg Krontveit, Kristin Helene Svanqvist · 2017 · Drugs & Aging
91. Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications
    Sydney B. Ross, Émilie Bortolussi‐Courval, Ryan Hanula, Todd Campbell Lee, Marnie Goodwin Wilson, Emily Gibson McDonald · 2022 · JAMA Network Open
92. Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case–control study in a large population-based German database
    Kathrin Jobski, Sigrid Behr, Edeltraut Garbe · 2011 · European Journal of Clinical Pharmacology
93. Triple Therapy for Atrial Fibrillation after PCI
    Jonathan Paul Piccini, W. Schuyler Jones · 2017 · New England Journal of Medicine
94. Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
    Takao Tamura, Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno · 2012 · International Journal of Medical Sciences
95. Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention
    Nileshkumar Patel, Dhaval Pau, Nikhil Nalluri, Parth J. Bhatt, Badal Thakkar, Ritesh Kanotra, Kanishk Agnihotri, Nitesh Ainani, Nilay Patel, Nish Patel et al. · 2016 · The American Journal of Cardiology
96. The mortality reducing effect of aspirin in colorectal cancer patients: Interpreting the evidence
    Martine A. Frouws, Myrthe P. P. van Herk‐Sukel, Huub A. Maas, Cornelis J.�H. van de Velde, Johanneke E.A. Portielje, Gerrit‐Jan Liefers, Esther Bastiaannet · 2017 · Cancer Treatment Reviews
97. Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
    Gregorio Tersalvi, Luigi Biasco, Giacomo Maria Cioffi, Giovanni Battista Pedrazzini · 2020 · Journal of Clinical Medicine
98. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation
    Daniele Pastori, Pasquale Pignatelli, Alessio Farcomeni, Roberto Cangemi, William Robert Hiatt, Simona Bartimoccia, Cristina Nocella, Tommasa Vicario, Tommaso Bucci, Roberto Carnevale et al. · 2015 · American Heart Journal
99. Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts’ standpoint
    Jacek Kubica, Piotr Adamski, Przemysław Paciorek, Jerzy Robert Ładny, Zbigniew F. Kalarus, Waldemar Banasiak, Wacław Kochman, Jarosław Gorący, Beata Wożakowska−Kapłon, Eliano Pio Navarese et al. · 2018 · Cardiology Journal
100. Update on antithrombotic therapy after percutaneous coronary revascularisation
     Thomas Cuisset, Freek W.A. Verheugt, Laura Mauri · 2017 · The Lancet